The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India
The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
The center brings together hands on technology demonstrations, application expertise, and commercial operations
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
Subscribe To Our Newsletter & Stay Updated
